Immunostaining revealed high NNMT expression in the invasive tumor front showing MELF pattern, suggesting the potential of NNMT inhibitors, envisioned for metabolic disorder treatment, as effective for managing EEC. This evidence concerns the gene NNMT and Other metabolic disease.